Member Info for BuenaVista

Q: Is there any lock-in commitment for the cornerstone investor?

Gemini: In standard equity markets and IPOs, cornerstone investors are almost always required to sign a lock-up agreement, typically committing them to hold their shares for a specified duration (commonly 6 to 12 months) to ensure market stability post-transaction.

However, in this specific June 5, 2026 secondary placing by Avacta on London's AIM, the regulatory disclosure does not specify a mandatory lock-up period for the cornerstone institutional investor.

The structural dynamics of this specific deal indicate why a rigid lock-in commitment was likely absent or structured differently:

1. Secondary Market Placing vs. IPO: This is an accelerated secondary placing of existing/new ordinary shares to raise immediate capital rather than an Initial Public Offering (IPO). In secondary placements, lock-ups are less systematically enforced on incoming institutional buyers compared to founders or insiders.

2. Immediate Strategic Use of Funds: The transaction was initiated for a highly specific emergency objective: to pay off a near-term Convertible Bond debt acceleration deadline (with a key trigger date of June 30, 2026). Avacta accepted a cornerstone buyer to fast-track cash generation at 70p per share to avoid major share dilution.

3. No Market Discount: Because the cornerstone investor agreed to buy the majority of the shares at 70p—which perfectly matched the mid-market closing price of the prior day—there was no deeply discounted "cheap equity" that would incentivize an immediate dump of shares into the market.

While a formal, multi-month lock-up is not explicitly cited in Avacta's regulatory announcement for this specific placement, cornerstone institutional funds are conceptually long-only "sticky capital" rather than short-term momentum traders.

Q: What does "cornerstone investor" mean—and what is its commitment—in this context from https://www.lse.co.uk/rns/AVCT/oversubscribed-strategic-equity-fundraise-of-1639m-sgxskg528finfw7.html : "LONDON and PHILADELPHIA - June 5, 2026 - Avacta Therapeutics (AIM: AVCT, the "Company", the "Group", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, is pleased to announce that it has raised gross proceeds of approximately £9 million from institutional investors and existing shareholders, with one institutional cornerstone investor representing the majority of the funds."

Gemini: In the context of equity fundraising and initial public offerings (IPOs), a cornerstone investor is a high-profile, institutional investor who commits to purchasing a substantial, predetermined amount of shares before the fundraising or bookbuilding process goes public.

Meaning and Strategic Value — A cornerstone investor acts as an anchor for the fundraising round. Their involvement serves several critical functions:

• Validation and Credibility: It signals deep institutional confidence in the company’s underlying technology (in this case, Avacta’s pre|CISION® oncology platform) and valuation, which helps de-risk the investment for other market participants.

• Momentum: Securing a major buyer upfront stimulates demand, heavily contributing to why this specific fundraise could be announced as "oversubscribed."

Their Commitment in This Context — Based on the text provided, the specific commitment of this cornerstone investor is:

• Majority Financial Backing: Out of the total £9 million raised, this single institutional investor committed to providing the majority of the funds (i.e., more than £4.5 million).

• Early Capital Guarantee: They legally bound themselves to purchase these shares prior to the closing of the round, guaranteeing Avacta a successful baseline of capital regardless of how other public or institutional investors reacted.

LDA wrote: "Read a great article recently on the kremlin playbook and really do feel it sums up wyndrym et al best to ignore all the aliases

Here is a synopsis

Weaponizing victimhood is a calculated manipulation tactic in which individuals exaggerate or fabricate grievances to exploit others' empathy, evade accountability, and gain power. It flips power dynamics, allowing the aggressor to cast themselves as the injured party while their actual victims are painted as perpetrators"

This 'Kremlin' playbook is the play of all fascists/narcissists. Hitler used it. Farage uses it. Trump uses it. A couple here use it. It plays very well with the ignorant and fearful but it is totally disingenuous and can allow the perpetraitors to gain advantage.

Eggy's gone off again.

https://www.lse.co.uk/profiles/teabag66/

Just the stench of fish now.

Does anyone else find it weird that someone who isn't invested in the company and doesn't know what it does spends all day every day hanging around this BB?

Do you mean a deal on BP's terms or a deal on Avacta's terms?

You truly are one dim PoS.

No one has said that "Avacta NEED to raise cash right now to strengthen its negotiating position". That is your corrupting interpretation of what was said. But having cash, and importantly being able to demonstrate that it can raise lots of cash to cover it's financial commitments very easily, does strengthen its negotiating position.

If you don't understand this then come back and I'll advise you further.

Today's funding announcement does several things, including strengthening Avacta's negotiating position. If you can't see — rather than won't acknowledge — that then just stick to your own version of being a 'wise' investor.

Funny but sad in a Walter Mitty sort of way.

Crossed posts

SeethreeIPO and crowfoot, are you saying Heights could have known about all of today's announcement ahead of time — that is, during the time the share price was falling. I'd be interested to know whether Heights have a channel that makes them privy to Avacta's financial plans. I doubt there is such a channel but, if there is, tell us!

This clown isn't even invested

Do you think Heights knew ahead of time about this raise and were shorting Avacta?

It would be stabilising to get some TR1s but what I suspect is happening here is that those who know they will be getting cheap shares sell some or all of their Avacta holding and bank the profit when they get their issued shares and that's why the share price falls before these fundraisers are announced.

Avacta's HNWIs forward selling in my opinion.

Indeed!

"...we expect that [the AVA6000 and AVA6103 trials] data will provide validation of our pre|CISION® technology in patients, by demonstrating that both our First and Second Gen molecules can effectively treat human cancers."

"Expect" is a very strong future looking verb.

AXA Framlington Biotech?

It also strengthens Avacta's negotiating position in discussions with potential partners and licensees

I'll be looking to add below 70p.

As the wyndbum knows, if retail had been included in the offer, the share price and the issue price would have been lower.

This disingenuous attitude is why this wyndbum piece of doggy dos with its long sermons is detested here.

Opening fundraisers for retail investors has in the past led to share price collapse. Would that have been different this time?